Skip to main content

Table 1 Baseline characteristics of included infants, timing of surfactant doses, collection of samples and microbiological findings

From: Microbiological analyses of nasally guided catheters after less invasive surfactant administration – a pilot study

No.

Gestational age at birth in weeks

Weight at birth in gram

Time of surfactant administration after birth in hours: minutes

*cultured sample; *e collected, but excluded; -- missed

Microbiological findings Bacterium (Colony Forming Units (CFU))

1st dose

2nd dose

3rd dose

1

24 + 5/7

345

00:13 --

09:09 *

viridans group streptococci (160 CFU)

2

33 + 2/7

1730

34:23 *

3

29 + 0/7

1190

05:30 *

4

29 + 6/7

1600

00:22 --

17:22 *

5

25 + 0/7

660

02:10 *e

17:50 *

6

27 + 2/7

980

01:02 *

7

31 + 4/7

2145

00:12 *

8

28 + 6/7

1340

01:49 *

9

31 + 2/7

1490

00:20 --

02:38 *

18:53 --

10

33 + 1/7

1990

25:21 *

viridans group streptococci (160 CFU) coagulase-negative staphylococci (90 CFU)

11

30 + 0/7

980

33:58 *

coagulase-negative staphylococci (30 CFU)

12

30 + 2/7

1220

00:08 *

13

26 + 6/7

655

26:21 *

14

25 + 4/7

495

02:24 *

37:09 --

15

25 + 2/7

685

00:43 *

Staphylococcus aureus(60 CFU)

16

29 + 5/7

1380

02:56 *

17

24 + 6/7

880

01:14 *

16:12 *e

18

25 + 4/7

555

01:03 --

14:20 *

19

27 + 1/7

585

00:27 *

20

30 + 0/7

780

14:21 --

17:55 *e

21:40 *